DJ Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 2.68% to $1.09 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.05% to 25,508.07 and Dow Jones Industrial Average falling 0.59% to 51,839.26.
Inovio Pharmaceuticals Inc. closed 63.41% short of its 52-week high of $2.98, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.67% to $248.82, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 1.20% to $24.75.
Trading volume (2.0 M) remained 495,726 below its 50-day average volume of 2.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 20, 2026 17:25 ET (21:25 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments